Literature DB >> 1601533

Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43.

E Diletti1, D Hauschke, V W Steinijans.   

Abstract

For the two-period crossover design and a multiplicative model (logarithmic normal distribution) the decision procedure of choice is based on the inclusion of the shortest 90%-confidence interval for the ratio of expected medians for test and reference in the equivalence range. This inclusion rule is equivalent to the two one-sided tests procedure. Sample sizes based on the power of the latter have been given by Diletti et al. [1991] for an equivalence range of 0.8 to 1.25. Corresponding tables for the tighter equivalence range of 0.9 to 1.11 as well as for the wider range of 0.7 to 1.43 are given in this amendment.

Mesh:

Year:  1992        PMID: 1601533

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  3 in total

1.  Novel scaled average bioequivalence limits based on GMR and variability considerations.

Authors:  Vangelis Karalis; Mira Symillides; Panos Macheras
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

2.  Improved ziprasidone formulations with enhanced bioavailability in the fasted state and a reduced food effect.

Authors:  Avinash G Thombre; Scott M Herbig; Jeffrey A Alderman
Journal:  Pharm Res       Date:  2011-06-15       Impact factor: 4.200

3.  Gender Variations in Pharmacokinetics of Paracetamol in Hausa/Fulani Ethnic group in Northwest Nigeria - A Two-stage Approach.

Authors:  Umar Muhammad Tukur; Shaibu Oricha Bello
Journal:  Int J Appl Basic Med Res       Date:  2021-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.